HES: review of pharmacokinetics, dynamics, current products, etc. JVECC 2014 Flashcards

1
Q

What is HES synthesized from?

A

amylopectin
- natural starch derived from corn/potatoes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 3 numbers provided by the HES manufacturer?

A

average molecular weight (MW)
molecular substitution (MS)
pattern of substitution (C2/C6 ratio)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the names of HES with molecular substitutions of 0.4, 0.5, 0.6, or 0.7?

A
  • tetrastarch
  • pentastarch
  • hexastarch
  • hetastarch
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the molecular weight of albumin in dogs?

A

64-67 kDa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What do these numbers represent?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Name the modified Starling’s equation

A

Jv = Kf (HPc - HPi) - ohm (COPc - COPg)

JV = net fluid movement across the capillary
Kf = filtration coefficient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why was 6% hetastarch formerly labeled with a lower molecular weight average?

A

because the weight could be determined more accurately with a newer method (low-angle laser light scattering)

previous method: chromatography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the glomerular molecular weight filtration threshold?

A

45-60 kDa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

If HES molecules’ size is above the glomerular filtration threshold

A

alpha-amylase breaks larger molecules down –> until small enough to be filtered through the glomerulus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What determines how long HES remain in the intravascular space? (MW, MS or C2/C6 ratio)

A

all
- larger molecules –> must be broken down into smaller parts before excretion
- higher molar substitution –> higher number of sites of substitution (e.g., hetastart compared to hexastarch) –> reduces access of alpha-amylase to the intermoleculalr bonds for degradation
- higher C2/C6 ratio –> HE groups positioned on the C2 atom block alpha-amylase more effectively

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What characteristic of HES are the most important for determining pharmacokinetics?

A

molar substitution and pattern of substitution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Do dogs or people eliminate HES faster?

A

dogs - shorter half-life because of higher plasma alpha-amylase concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the mechanisms of HES elimination?

A
  • renal - 70% (the smaller the molecule the faster, because of glomerular filtration)
  • transient storage in the reticuloendothelial cells of liver, spleen, lymph nodes, IV and interstitial spaces (increased tissue storafe with increased molar substitution
  • bile excretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

List 5 reported side effects of HES administration (including in people)

A
  • volume overload
  • coagulopathies
  • AKI
  • proinflammatory effects
  • allergic reactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the presumed mechanisms of AKI from HES administration?

A
  • HES macromolecule reabsorbtion into proximal renal tubular cells –> osmotic nephrosis (vacuolization and swelling of cells)
  • hyperoncotic AKI, i.e., increased intravascular COP reduces glomerular filtration
  • backleak of filtrate across damaged tubular epithelium
  • dilutional hypoalbuminemia - decreased levels of renoprotective albumin
16
Q

According to a recent Cochrane review, what subcategory of critically ill patients is at a higher risk of AKI from HES administration?

A

Sepstic patients

17
Q

After administering HES to dogs, what changes may occur on the urine analysis?

A

increased specific gravity - no changes to osmolality

18
Q

List 4 coagulation abnormalities reported with HES administration

A
  • platelet dysfunction (decreased adhesion)
  • decreased vWF
  • decreased FVIII
  • hyperfibrinolysis
19
Q

How does HES affect platelets?

A

HES molecules bind to platelet bindings sites (not the fibrinogen one)

20
Q

How do coagulopathic effects of tetrastarch and hetastarch differ?

A

tetrastarch
* less PLT inhibition
* less vWF-VIII binding (because excreted faster)
* more hyperfibrinolysis

21
Q

How does tetrastarch increased fibrinolysis?

A

disrupts the thrombin-TAFI relationship

22
Q

What is the initial expansion volume of 450 mL of 6% Hetastarch in healthy normovolemic patients at time 0 and 30 min?

A

450 min time 0
>650 mL 30 min later

23
Q

How did the initial and delayed plasma expansion compare between 0.9% NaCl and HES in Silverstein et al?

A

0.9% NaCl caused more plasma volume expansion initially but fell below HES 30 min later

24
Q

What is the normal Colloid osmotic pressure in healthy dogs?

A

17.5 - 22.7 mm Hg

25
Q

What is the reported colloid osmotic range in hypoalbuminemic dogs?

A

5.8 - 12.7 mm Hg

26
Q

What are the two theories of how HES administration helps with capillarby hyperpermeability?

A
  • plugging intercellular gaps
  • immunomodulators